Grab This Deal Even Lower Than Director Doordan Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 8, DexCom Inc's Director, Martin Doordan, invested $20,709.00 into 2,000 shares of DXCM, for a cost per share of $10.35.